3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Fallopian Tube Neoplasms
4
Adenocarcinoma Of Esophagus
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Melanoma
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Triple Negative Breast Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Anatomic Stage I Breast Cancer AJCC v8
2
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Pancreatic Cystic Neoplasm
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Mouth Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Locally Advanced Cervical Adenocarcinoma
1
Laryngeal Neoplasms
1
Interventions
Dexamethasone
44
Lenalidomide
29
Bortezomib
23
daratumumab
22
pomalidomide
19
Cyclophosphamide
15
carfilzomib
14
Specimen Handling
14
Biopsy
14
Calcium Dobesilate
12
Magnetic Resonance Spectroscopy
10
talquetamab
9
isatuximab
9
Melphalan
8
iberdomide
7
fludarabine
7
belantamab mafodotin
6
dexamethasone acetate
5
dexamethasone 21-phosphate
5
auricularum
5
X-Rays
5
tocilizumab
4
selinexor
4
fludarabine phosphate
4
elotuzumab
4
Nuclear Medicine Department, Hospital
4
trametinib
3
dabrafenib
3
Whole-Body Irradiation
3
Thalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Taxes
×
30 days
×
Clear all
No trials found.